Featured series 
Tag: Melanoma
-
Nation & World
The social life of a dermatologist
It might be jarring when a friend, or complete stranger, pulls down their shirt while you’re trying to eat dinner. It’s also an opportunity.
-
Nation & World
How mutant protein leads to melanoma
Discovery of new mechanism could have wide implications for other cancers.
-
Nation & World
New AI tool can predict melanoma recurrence
A new AI tool may help clinicians determine which early stage melanoma patients would likely benefit from aggressive treatment even at the onset of the disease.
-
Nation & World
Eating fish linked to skin cancer risk
In a new study researchers determined that people who eat about 2.6 servings of fish per week have a higher risk for the skin cancer melanoma.
-
Nation & World
Cancer vaccine shows durable immune effects
Researchers at Harvard Medical School and affiliated institutions have shown that a personalized cancer vaccine that is specific to an individual’s tumor has lasting effects, detecting vaccine-related immune system changes years after the vaccine was given.
-
Nation & World
Drop in cancer deaths lifts U.S. life expectancy
A decline in cancer mortality was a prominent feature of recent good news about U.S. life expectancy. The Gazette spoke with the director of the Chan School’s Zhu Family Center for Global Cancer Prevention to understand why.
-
Nation & World
Feel like kids, spouse, work giving you gray hair? They may be
Harvard scientists have found evidence to support long-standing anecdotes that stress turns hair gray.
-
Nation & World
A cancer’s surprise origins, caught in action
Researchers have found that cancer begins after activation of an oncogene or loss of a tumor suppressor, and involves a change that takes a single cell back to a stem cell state. They believe this model may apply not only to melanoma, but to most if not all cancers.
-
Nation & World
Skin cancer detection breakthrough
Researchers at Harvard-affiliated Brigham and Women’s Hospital have pinpointed when seemingly innocuous skin pigment cells mutate into melanoma.
-
Nation & World
When skin cancer cells resist drug treatment
Harvard researchers have found that although tailored drugs can eradicate melanoma cells in the lab, they often produce only partial, temporary responses in patients. Researchers have now learned that normal cells that reside within the tumor, part of the tumor microenvironment, may supply factors that help cancer cells grow and survive despite the presence of…
-
Nation & World
A data bank to battle cancer
Researchers at Brigham and Women’s Hospital and the Dana-Farber Cancer Institute are collaborating on a massive, long-term effort to collect and analyze tumor tissue from 10,000 cancer patients annually. The researchers hope the data will enable them to understand better how tumors behave, while providing opportunities to test new therapies.
-
Nation & World
Increasing risk for melanoma
A major international study has identified a novel gene mutation that appears to increase the risk of both inherited and sporadic cases of malignant melanoma, the most deadly form of skin cancer.
-
Nation & World
Predicting cancer’s spread
Harvard researchers at Dana-Farber Cancer Institute (DFCI) have identified a number of cancer genes that endow melanoma tumors with the ability to metastasize, making it possible to predict whether the tumors are likely to spread.
-
Nation & World
Increasing odds for survival
A duo of drugs, each targeting a prime survival strategy of tumors, can be safely administered and is potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial led by Harvard investigators at the Dana-Farber Cancer Institute.
-
Nation & World
Progress against melanoma
Harvard stem cell researchers at Children’s Hospital Boston have taken two important steps toward development of a new way of treating melanoma, the most virulent form of skin cancer.
-
Nation & World
Critical finding for skin cancer treatment
Researchers’ findings pinpoint a critical gene involved in melanoma growth, and provide a framework for discovering ways to tackle cancer drug resistance.
-
Nation & World
A Cancer Visible To The Naked Eye, But Doctors Aren’t Looking
“We were very, very surprised,” Geller recalls. “About three-quarters of them were never trained in the skin cancer exam, and more than half never once practiced the examination during their primary care residency.” Geller, who’s a senior research scientist at the Harvard School of Public Health, says those high levels of inexperience are really worrisome.…